Samrat Pharmachem Limited engages in the manufacture and sale of pharmaceutical chemicals in India. It offers 3-5-di iodosalicylic acid, ammonium iodide, cadmium iodide, calcium iodate, clioquinol, copper iodide, ethyl iodide, ethylenediamine dihydroiodide, hydroiodic acid, iodine, iodine monochloride, iodoquinol, methyl iodide, n-iodo succinimide, periodic acid, potassium iodate and iodide, potassium metaper iodate, povidone iodine, sodium iodate and iodide, and sodium metaper iodate. The company serves the agrochemical, animal feed, chemical, cosmetics, food, pharmaceutical, printing, and textile industries. It also exports its products to the United States, Europe, Africa, Asia, the Middle East, and internationally. Samrat Pharmachem Limited was incorporated in 1992 and is based in Mumbai, India.
| Current Price | ₹207.80 |
|---|---|
| Market Cap | ₹64 Cr |
| Sector | Materials > Materials > Chemicals |
| Sub-Industry | Specialty Chemicals > 0 |
| P/E Ratio | -19.4 |
| Return on Equity | -4.73% |
| 52-Week Range | ₹190.00 – ₹389.00 |
| Beta (1Y) | 0.54 |
| Dividend Yield | 0.48% |
Samrat Pharmachem Ltd. is trading at ₹207.80, with a market capitalisation of ₹64 Cr.
Samrat Pharmachem Ltd. operates in the Materials > Materials > Chemicals space (Specialty Chemicals > 0).
Samrat Pharmachem Ltd. has a P/E of -19.4 and a return on equity of -4.73%.